(Tromsø 03. May 2017) Rolf E. Engstad, CSO of Biotec BetaGlucans has today
purchased 30 000 shares in Biotec Pharmacon at NOK 5.78 per share. After this
transaction holds Engstad 350.774 shares and 110.000 options in Biotec
Pharmacon
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no

